Boston Heart Lab Corp. completes a $10 million equity and options-based funding round.
Boston Heart Lab Corp. closed a $10 million funding round, according to a Securities & Exchange Commission filing.
The Framingham, Mass.-based heart disease tests began the sale of equity and options July 26.
These Are the Top-Rated Autism Therapy Centers in Texas
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
According to the filing, a total of 46 investors were involved in the round. The document names former Cequent Pharmaceuticals Inc. CEO and current Boston Heart Lab chairman Peter Parker as a director, while Jeff Crisan and Alice Limkakeng of Boston-based Bain Capital Ventures are also named as directors.
Boston Heart Lab’s CEO is Susan Hertzberg, a former Quest Diagnostics executive, according to its website.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.